DECIPHER clinical trial: Member of the Trial Steering Committee

Activity: Other activity typesOther

Description

A single arm phase II trial of trastuzumab deruxtecan in patients with gastrooesophageal adenocarcinoma cancer who are ctDNA and HER2 positive.
Period01 Feb 202310 Mar 2023
Held atUniversity of Cambridge, United Kingdom
Degree of RecognitionInternational